Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Orthotopic heart transplant versus left ventricular assist device: a national comparison of cost and survival.

Mulloy DP, Bhamidipati CM, Stone ML, Ailawadi G, Kron IL, Kern JA.

J Thorac Cardiovasc Surg. 2013 Feb;145(2):566-73; discussion 573-4. doi: 10.1016/j.jtcvs.2012.10.034. Epub 2012 Dec 13.

2.

The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Hutchinson J, Royle P, Bryant J.

Health Technol Assess. 2005 Nov;9(45):1-132, iii-iv. Review.

3.

How does successful bridging with ventricular assist device affect cardiac transplantation outcome?

Urban M, Pirk J, Dorazilova Z, Netuka I.

Interact Cardiovasc Thorac Surg. 2011 Oct;13(4):405-9. doi: 10.1510/icvts.2011.273722. Epub 2011 Jul 25. Review.

PMID:
21788304
4.

Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review.

Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P.

Can J Cardiol. 2013 Dec;29(12):1712-20. doi: 10.1016/j.cjca.2013.05.014. Epub 2013 Aug 23. Review.

PMID:
23978595
5.

Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt JL, Royle P, Bryant J.

Eur Heart J. 2006 Dec;27(24):2929-38. Epub 2006 Apr 7. Review.

PMID:
16603577
6.

Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2016 Feb 8;16(3):1-60. eCollection 2016. Review.

7.

Heart transplantation and left ventricular assist device therapy: two comparable options in end-stage heart failure?

Garbade J, Barten MJ, Bittner HB, Mohr FW.

Clin Cardiol. 2013 Jul;36(7):378-82. doi: 10.1002/clc.22124. Epub 2013 Apr 17. Review.

8.

A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.

Nunes AJ, MacArthur RG, Kim D, Singh G, Buchholz H, Chatterley P, Klarenbach SW.

Value Health. 2016 Jun;19(4):494-504. doi: 10.1016/j.jval.2014.12.020. Review.

PMID:
27325342
9.

Matching the Market for Heart Transplantation.

Hsich EM.

Circ Heart Fail. 2016 Apr;9(4):e002679. doi: 10.1161/CIRCHEARTFAILURE.115.002679. Review.

10.

Left ventricular assist device: a bridge to transplant or destination therapy?

Patel S, Nicholson L, Cassidy CJ, Wong KY.

Postgrad Med J. 2016 May;92(1087):271-81. doi: 10.1136/postgradmedj-2015-133718. Epub 2016 Mar 11. Review.

PMID:
26969730
11.

Ventricular arrhythmias after left ventricular assist device.

Nakahara S, Chien C, Gelow J, Dalouk K, Henrikson CA, Mudd J, Stecker EC.

Circ Arrhythm Electrophysiol. 2013 Jun;6(3):648-54. doi: 10.1161/CIRCEP.113.000113. Review. No abstract available.

12.

Mechanical circulatory support for destination therapy.

Tozzi P, Hullin R.

Swiss Med Wkly. 2016 Mar 5;146:w14267. doi: 10.4414/smw.2016.14267. eCollection 2016. Review.

13.

Left ventricular assist device outflow cannula obstruction by the rare environmental fungus Myceliophthora thermophila.

Weitzel N, Puskas F, Cleveland J, Levi ME, Seres T.

Anesth Analg. 2009 Jan;108(1):73-5. doi: 10.1213/ane.0b013e318187b8fc. Review.

PMID:
19095833
14.

Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation.

Clegg AJ, Scott DA, Loveman E, Colquitt J, Royle P, Bryant J.

Int J Technol Assess Health Care. 2007 Spring;23(2):261-8. Review.

PMID:
17493313
15.

Left ventricular assist device and heart transplantation in hemophilia a patient.

Quader M, Rusina Z, Lewis NP, Martin L, Katlaps G.

Ann Thorac Surg. 2013 Dec;96(6):2245-7. doi: 10.1016/j.athoracsur.2013.04.095. Review.

PMID:
24296201
16.

Cardiac failure, transplantation and donation: current perspectives.

Ashraf O, Sharif H.

J Cardiovasc Surg (Torino). 2015 Aug;56(4):661-9. Epub 2013 May 29. Review.

PMID:
23719618
17.

State of the art. Circulatory support.

Kantrowitz A.

ASAIO Trans. 1988 Jul-Sep;34(3):445-9. Review.

PMID:
3058180
18.

Cost-effectiveness of heart failure therapies.

Rohde LE, Bertoldi EG, Goldraich L, Polanczyk CA.

Nat Rev Cardiol. 2013 Jun;10(6):338-54. doi: 10.1038/nrcardio.2013.60. Epub 2013 Apr 23. Review.

PMID:
23609174
19.

Clinical, molecular, and genomic changes in response to a left ventricular assist device.

Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, Baba HA, Wohlschlaeger J, Miller LW.

J Am Coll Cardiol. 2011 Feb 8;57(6):641-52. doi: 10.1016/j.jacc.2010.11.010. Review.

20.

Spontaneous hyphema and pupillary block in a patient with a left ventricular assist device.

Kavoussi SC, Liu J.

Digit J Ophthalmol. 2015 Jun 11;21(2):1-9. doi: 10.5693/djo.02.2015.04.003. eCollection 2015. Review.

Supplemental Content

Support Center